Telomerase activity, hTERT expression, and phosphorylation are downregulated in CD4+ T lymphocytes infected with human immunodeficiency virus type 1 (HIV-1)

Journal of Medical Virology

Volumn 79, Issue 5, 2007, Pages 639-646

  Franzese, Ornella ^a,b   Adamo, Riccardo ^a   Pollicita, Michela ^a   Comandini, Alessandro ^a   Laudisi, Anastasia ^a   Perno, Carlo Federico ^a   Aquaro, Stefano ^a,c   Bonmassar, Enzo ^a  

^a UNIVERSITY OF ROME TOR VERGATA   (Italy)

^b UNIVERSITY COLLEGE LONDON   (United Kingdom)

^c UNIVERSITY OF CALABRIA   (Italy)

Author keywords

Activation; CD4; HIV 1; hTERT; Phosphorylation; Telomerase

Indexed keywords

IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; PHOSPHOPROTEIN PHOSPHATASE 2A; PROTEIN KINASE B; TELOMERASE; TELOMERASE REVERSE TRANSCRIPTASE;

ARTICLE; CD4+ T LYMPHOCYTE; CELL DIVISION; CELL NUCLEUS; CELL PROLIFERATION; CONTROLLED STUDY; ENZYME ACTIVATION; ENZYME ACTIVITY; ENZYME PHOSPHORYLATION; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1 INFECTION; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; SERODIAGNOSIS; TELOMERE;

CD4-POSITIVE T-LYMPHOCYTES; CELL NUCLEUS; CELLS, CULTURED; CYTOPLASM; DOWN-REGULATION; HIV INFECTIONS; HIV-1; HUMANS; PHOSPHORYLATION; TELOMERASE;

HUMAN IMMUNODEFICIENCY VIRUS 1;

EID: 34147095386     PISSN: 01466615     EISSN: 10969071     Source Type: Journal    
DOI: 10.1002/jmv.20855     Document Type: Article

References (37)

1. Akiyama M, Hideshima T, Hayashi T, Tai Y, Mitsiades CS, Mitsiades N, Chauhan D, Richardson P, Munshi NC, Anderson KC. 2003. Nuclear Factor-B p65 mediates tumor necrosis factor-induced nuclear translocation of telomerase reverse transcriptase protein 1. Cancer Res 63:18-21.
2. Andrews NC, Faller DV. 1991. A rapid micropreparation tehcnique for extraction of DNA-binding proteins from limiting numbers of mammalian cells. Nucleic Acids Res 19:2499.
3. Arroyo JD, Hahn WC. 2005. Involvement of PP2A in viral and cellular transformation. Oncogene 24:7746-7755.
4. Artandi SE, Attardi LD. 2005. Pathways connecting telomeres and p53 in senescence, apoptosis, and cancer. Biochem Biophys Res Commun 331:881-890.
5. Ballon G, Ometto L, Righetti E, Cattelan AM, Masiero S, Zanchetta M, Chieco Bianchi L, De Rossi A. 2001. Human immunodeficiency virus type 1 modulates telomerase activity in peripheral blood lymphocytes. J Infect Dis 183:417-424.
6. Bestilny LJ, Gill MJ, Mody CH, Riabowol KT. 2000. Accelerated replicative senescence of the peripheral immune system induced by HIV infection. AIDS 14:771-780.
7. Bostik P, Dodd GL, Patel SS, Kadivar H, Ansari AA. 2001. Effect of productive in vitro human immunodeficiency virus or simian immunodeficiency virus infection on telomerase activity in lymphoid and nonlymphoid cells. J Infect Dis 183:417-424.
8. Chung HK, Cheong C, Song J, Lee HW. 2005. Extratelomeric functions of telomerase. Curr Mol Med 5:233-241.
9. Dagarag M, Ng H, Lubong R, Effors RB, Yang OO. 2003. Differential impairment of lytic and cytokine funcions in senescent human immunodeficiency virus type 1-specific cytotoxic T lymphocytes. J Virol 77:3077-3083.
10. Effros RB. 2004. Impact of the Hayflick Limit on T cell responses to infection: Lessons from aging and HIV disease. Mech Ageing Dev 125:103-106.
11. + T cells. Cell Death Differ 11:782-784.
12. Haendeler J, Hoffmann J, Rahman S, Zeiner AM, Dimmeler S. 2003. Regulation of telomerase acttivity and anti-apoptotic function by protein-protein interaction and phosphorylation. FEBS Lett 536: 180-186.
13. Hathcock KS, Chiang YJ, Hodes RJ. 2005. In vivo regulation of 1 telomerase activity and telomere length. Immunol Rev 205:104-113.
14. +T cells and in vitro. J Cell Biochem 94:816-825.
15. Janssens V, Goris J, Van Hoof C. 2005. PP2A: The expected tumor suppressor. Curr Opin Genet Dev 15:34-41.
16. 3. Immunol Rev 192:7-20.
17. Kang SK, Taegun K, Do YK, Su I. 1999. Akt protein kinase enhances human telomerase activity through phosphorylation of telomerase reverse transcriptase subunit. J Biol Chem 274:13085-13090.
18. Kawauchi K, Ihjima K, Yamada O. 2005. IL-2 increases human telomerase reverse transcriptase activity transcriptionally and posttranslationally through phosphatidylinositol 3′-kinase/Akt, heat shock protein 90, and mammalian target of rapamycin in transformed NK cells. J Immunol 174:5261-5269.
19. Li H, Zhao LL, Funder JW, Liu JP. 1997. Protein phosphatase 2A inhibits nuclear telomerase activity in human breast cancer cells. J Biol Chem 272:16729-16732.
20. Liang J, Slingerland JM. 2003. Multiple roles of the PI3K/PKB (Akt) pathway in cell cycle progression. Cell Cycle 2:339-345.
21. Liu K, Hodes RJ, Weng N. 2001. Telomerase activation in human T lymphocytes does not require increase in telomerase reverse transcriptase (hTERT) protein but is associated with hTERT phosphorylation and nuclear translocation. J Immunol 166:4826-4830.
22. + helper and regulatory T-cell clones and confers resistance to oxidative stress-induced apoptosis. Blood 101:4512-4519.
23. Millward TA, Zolnierowicz S, Hemmings BA. 1999. Regulation of protein kinase cascades by protein phosphatase 2A. Trends Biochem Sci 24:186-191.
24. Nakajima A, Tauchi T, Sashida G, Sumi M, Abe K, Yamamoto K, Ohyashiki JH, Ohyashik K. 2003. Telomerase inhibition enhances apoptosis in human acute leukemia cells: Possibility of antitelomerase therapy. Leukemia 17:560-567.
25. + T-lymphocyte senescence fraction in advanced human immunodeficiency virus type 1 infection. Scand. J Immunol 49:302-306.
26. + T cells from HIV-discordant monozygotic twins. J Exp Med 185:1381-1386.
27. Perfettini JL, Castedo M, Roumier T, Andreau K, Nardacci R, PiacentiniM, Kroemer G. 2005. Mechanisms of apoptosis induction by the HIV-1 envelope. Cell Death Differ 12:916-923.
28. Seimiya H, Sawada H, Muramatsu Y, Shimizu M, Ohko K, Yamane K, Tsuruo T. 2000. Involvment of 14-3-3proteins in nuclear localization of telomerase. EMBO 19:2652-2661.
29. Sina-Datta U, Horikawa I, Michishita E, Datta A, Sigler-Nicot JC, Brown M, Kazanji M, Barret JC, Nicot C. 2004. Transcriptional activation of hTERT through the NF-kB pathway in HTLV-1-transformed cells. Blood 104:2523-2531.
30. Song G, Ouyang G, Bao S. 2005. The activation of Akt/PKB signaling pathway and cell survival. J Cell Mol Med 9:59-71.
31. Sung YH, Choi YS, Cheong C, Lee HW. 2005. The pleiotropy of telomerase against cell death. Mol Cells 19:303-309.
32. Tucker V, Jenkins J, Gilmour J, Savoie H, Easterbrook P, Gotch F, Browning MJ. 2000. T-cell telomere lenght maintained in HIV-infected long-term survivors. HIV Med 1:116-122.
33. Vignoli M, Stecca B, Furlini G, Re MC, Mantovani V, Zauli G, Visani G, Colangeli V, La Placa M. 1999. Impaired telomerase activity in uninfected haematopoietic progenitors in HTV-1-infected patients. AIDS 12:999-1005.
34. + T cells in HIV type 1 infection: A mathematical interpretation. AIDS Res Hum Retroviruses 15:1053-1062.
35. Wong JM, Collins K. 2003. Telomere maintenance and disease. Lancet 362:983-988.
36. Woodgett JR. 2005. Recent advances in the protein kinase B signaling pathway. Curr Opin Cell Biol 17:150-157.
37. Wu KJ, Grandori C, Amacker M, Simon-Vermot N, Polack A, Lingner J, Dalla-Favera R. 1999. Direct activation of TERT transcription by c-MYC. Nat Genet 21:220-2244.